Direxion Daily S&P Biotech Bear 3X ETF (LABD)
NYSEARCA: LABDDirexion FundsTrading--Inverse EquityETFUSD
Market open · Delayed 15 min · as of Oct 8, 9:50 AM ET
LABD chart
Full chartKey facts
- Expense ratio
- 1.07%
- Assets (AUM)
- $138.40M
- Dividend yield
- 6.53%
- Holdings
- —
- Inception
- May 28, 2015
- Issuer
- Direxion Funds
- Index tracked
- —
- Category
- Trading--Inverse Equity
- 52-week range
- 5.81 – 36.72
- Volume / Avg
- 4.25M / 17.87M
- Beta
- —
- Previous close
- 8.08
LABD ETF today
The Direxion Daily S&P Biotech Bear 3X ETF (LABD) is an exchange-traded fund from Direxion Funds in the Trading--Inverse Equity category. It charges an expense ratio of 1.07%, or $107.00 per year on a $10,000 investment, and manages $138.4 million in assets. LABD is down 61.6% year to date and has lost 77.9% over the past 12 months; over five years its price has changed -96.2%.
The fund's trailing dividend yield is 6.53%. LABD launched on May 28, 2015.
Summary generated from market data by MetaCap's automated system. Methodology
LABD performance
1 week
+14.94%
1 month
+20.96%
3 months
+15.10%
6 months
-47.09%
Year to date
-61.63%
1 year
-77.89%
3 years
-96.55%
5 years
-96.23%
LABD price return, excluding dividends.
ETFs similar to LABD
LABD ETF FAQ
What is the LABD price today?
LABD last traded at $8.43 as of Oct 8, 9:50 AM EDT, up 4.33% on the day.
What is LABD's expense ratio?
LABD has an expense ratio of 1.07%, which works out to about $107.00 per year for every $10,000 invested.
Does LABD pay a dividend?
Yes. LABD has a trailing dividend yield of 6.53% and pays quarterly distributions; the most recent was $0.071 per share with an ex-dividend date of Sep 22, 2026.
How big is LABD?
LABD has about $138.4 million in assets under management.